Investigation of Anti Inflammatory Activity of Triphala Hydrogels in Carrageenan Induced Paw Edema Model
DOI:
https://doi.org/10.22270/ajprd.v11i5.1315Keywords:
Triphala, Carrageenan, Anti inflammatoryAbstract
Inflammation is a reaction of a living vascularized tissue to an injury, conventional or synthetic drugs used in the treatment of inflammatory diseases are inadequate, it sometimes has serious stroke effects. So, number of herbal medicines are recommended for the treatment of inflammation that has no side effects. Hence our study focused to investigate bioactive compounds for anti-inflammatory activity. Folk medicine and ethnopharmacological data can provide a broad range of plants with promising anti-inflammatory activity. Triphala, an ayurvedic formula composed of three different plants. Terminalia chebula Retz., Terminalia bellerica Roxb(Combretaceae) and Phyllanthus emblica L is widely used for various microbial infections. Triphala is now evaluated for its anti-inflammatory action. Triphala is formulated into a hydrogel of different concentrations and is evaluated for in-vitro anti-inflammatory activity by membrane stabilization method at 100, 250 and 500 mg/ml and in-vivo evaluation is done by Carrageenan -induced paw edema method. The results obtained are compared with standard NSAID diclofenac hydrogel. The prepared hydrogel of triphala showed a dose-dependent anti-inflammatory potential in in-vivo and in-vitro methods which provide scientific basis for anti-inflammatory activity of Triphala.
Downloads
References
2. Atmakuri, Lakshmana Rao et al. “Current Trends in Herbal Medicines.” Journal of Pharmacy Research 3 (2010): 109-113
3. Zhang X, Zhang N, Kan J, Sun R, Tang S, Wang Z, Chen M, Liu J and Jin C: Anti-inflammatory activity of alkali-soluble polysaccharides from Arctium lappa L. and its effect on gut microbiota of mice with inflammation. International Journal of Biological Macromolecules 2020; 154: 773-87.
4. Anoop MV, Bindu AR. In-vitro Anti-inflammatory Activity Studies on Syzygium zeylanicum (L.) DC Leaves. International Journal of Pharma Research & Review. 2015; 4(8): 18-27.
5. Atmakuri, Lakshmana Rao et al. “Current Trends in Herbal Medicines.” Journal of Pharmacy Research 3 (2010): 109-113[Cross Ref]
6. Christine Tara Peterson, Kate Denniston, and Deepak Chopra. Therapeutic Uses of Triphala in Ayurvedic Medicine.The Journal of Alternative and Complementary Medicine. Aug 2017;607-614.
7. Lu K, et al. Triphala and its active constituent chebulinic acid are natural inhibitors of vascular endothelial growth factor-a mediated angiogenesis. 2012;7:e43934.
8. Belapurkar P, Goyal P, Tiwari-Barua P. Immunomodulatory effects of triphala and its individual constituents: A review. Indian J Pharm Sci 2014; 76:467–475.
9. Lee HS, et al. Antioxidant effects of aqueous extract of Terminalia chebula in vivo and in vitro. Biol Pharm Bull 2005; 28:1639–1644.
10. Reddy DB, et al. Chebulagic acid, a COX-LOX dual inhibitor isolated from the fruits of Terminalia chebula Retz., induces apoptosis in COLO-205 cell line. J Ethnopharmacol 2009; 124:506–512.
11. Baliga MS, et al. Scientific validation of the ethnomedicinal properties of the Ayurvedic drug Triphala: A review. Chin J Integr Med 2012; 18:946–954.
12. Winfield AJ, Richards RM. 2004.
13. Abad, L.V.; Relleve, L.S.; Aranilla, C.T.; Dela Rosa, A.M. Properties of radiation synthesized PVP-kappa carrageenan hydrogel blends. Radiat. Phys. Chem. 2003; 68: 901–908.
14. Ali, S.W.; Zaidi, S.A.R. Synthesis of copolymeric acrylamide/potassium acrylate hydrogels blended with poly (vinyl alcohol): Effect of crosslinking and the amount of poly (vinyl alcohol) on swelling behavior. J. Appl. Polym. Sci. 2005; 98:1927–1931.
15. Bhattarai, N.; Gunn, J.; Zhang, M. Chitosan-based hydrogels for controlled, localized drug delivery. Adv. Drug Deliv. Rev. 2010;62: 83–99.
16. Ahmed, E.M. Hydrogel: Preparation, characterization, and applications: A review. J. Adv. Res. 2015; 6: 105–121.
Published
How to Cite
Issue
Section
AUTHORS WHO PUBLISH WITH THIS JOURNAL AGREE TO THE FOLLOWING TERMS:
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 Unported License. that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
.